AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30548390 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (n=27)
Number of subjects: 53
Study 30548390 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 53
Study 30548390 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Metformin and Placebo)
Number of subjects: 53
Study 29795172 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - exercised twice a week at 85–95% of HRmax
Number of subjects: 30
Study 29795172 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Training (MIT) - exercised three times a week at 70% of HRmax
Number of subjects: 30
Study 29795172 — intervention group
Group type: COMPARATOR
Intervention: Control group - treatment as usual
Number of subjects: 30
Study 27716200 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet cognitive-behavioural therapy (CBT) with seven experimental factors (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, self-compassion training)
Number of subjects: 0
Study 27716200 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet cognitive-behavioural therapy (CBT) with seven experimental factors
Number of subjects: 0
Study 24449235 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling (TC)
Number of subjects: 669
Study 22140146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes with 10.1 μg ammonia per cigarette
Number of subjects: 34
Study 22140146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes with 18.9 μg ammonia per cigarette
Number of subjects: 34
Study 20694295 — intervention group
Group type: EXPERIMENTAL
Intervention: Agaricus sylvaticus (30 mg/kg/day)
Number of subjects: 56
Study 20694295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 18515949 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-regimens for fracture prevention
Number of subjects: 0
Study 18515949 — intervention group
Group type: EXPERIMENTAL
Intervention: External hip protector use
Number of subjects: 0
Study 18515949 — intervention group
Group type: COMPARATOR
Intervention: Comparison of different drug-regimens
Number of subjects: 0
Study 16164375 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-medical and non-surgical therapies for palliative care
Number of subjects: 15
Study 14523141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 114
Study 14523141 — intervention group
Group type: COMPARATOR
Intervention: Isotonic-saline hydration (Control)
Number of subjects: 114
Study 10551699 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 452
Study 10551699 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 452
Study 8752795 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine transesophageal echocardiography (5 and 10 microg/min per kg)
Number of subjects: 42
Study 8752795 — intervention group
Group type: EXPERIMENTAL
Intervention: F-18 fluorodeoxyglucose positron emission tomography
Number of subjects: 42
Study 8752795 — intervention group
Group type: COMPARATOR
Intervention: Segments with recovery of regional left ventricular function
Number of subjects: 42
Study 8752795 — intervention group
Group type: COMPARATOR
Intervention: Segments remaining akinetic after revascularization
Number of subjects: 42
Study 2071200 — intervention group
Group type: EXPERIMENTAL
Intervention: Pugh nail-plate
Number of subjects: 100
Study 2071200 — intervention group
Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 100
Study 29793605 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700 (infusion doses varying, continuous infusion for 30 minutes)
Number of subjects: 40
Study 29793605 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700 (higher dosages)
Number of subjects: 40
Study 29793605 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700 (upon ACTH stimulation)
Number of subjects: 40
Study 29793605 — intervention group
Group type: COMPARATOR
Intervention: Propofol (60 μg kg-1 min-1)
Number of subjects: 40
Study 29793605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27758992 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF assay
Number of subjects: 147
Study 27758992 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of positive Xpert MTB/RIF, positive tuberculin skin test, heterogeneous echotexture of lymph nodes, or endosonographic coagulation necrosis sign
Number of subjects: 147
Study 24810818 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 40
Study 24810818 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 23242731 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% caudally (0.5 ml/kg)
Number of subjects: 60
Study 23242731 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% caudally (0.5 ml/kg)
Number of subjects: 60
Study 23242731 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromage scale assessment for motor block
Number of subjects: 60
Study 20216112 — intervention group
Group type: EXPERIMENTAL
Intervention: TPV/RTV 500/100
Number of subjects: 10
Study 20216112 — intervention group
Group type: COMPARATOR
Intervention: TPV/RTV 500/200
Number of subjects: 10
Study 18667394 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI + gefitinib
Number of subjects: 100
Study 18667394 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 100
Study 16129748 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial opening-wedge high tibial osteotomy (HTO)
Number of subjects: 51
Study 16129748 — intervention group
Group type: COMPARATOR
Intervention: Lateral closing-wedge high tibial osteotomy (HTO)
Number of subjects: 51
Study 12538220 — intervention group
Group type: EXPERIMENTAL
Intervention: Brandt tube system
Number of subjects: 2
Study 12538220 — intervention group
Group type: COMPARATOR
Intervention: Hi-Contour control
Number of subjects: 2
Study 10989400 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus nurse home visits during pregnancy and through the child's second birthday (n = 116)
Number of subjects: 324
Study 10989400 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus nurse home visits during pregnancy only (n = 100)
Number of subjects: 324
Study 10989400 — intervention group
Group type: COMPARATOR
Intervention: Routine perinatal care (control group; n = 184)
Number of subjects: 324
Study 10989400 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation during pregnancy and infancy (for mothers reporting 28 or fewer incidents of domestic violence)
Number of subjects: 324
Study 10989400 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation during pregnancy and infancy (for mothers reporting more than 28 incidents of domestic violence)
Number of subjects: 324
Study 8903817 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate
Number of subjects: 98
Study 8903817 — intervention group
Group type: COMPARATOR
Intervention: Sulfate-free polyethylene glycol electrolyte lavage solution (SF-PEG-ELS)
Number of subjects: 98
Study 1801541 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (S) 10 mg/day
Number of subjects: 93
Study 1801541 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 93
Study 6401507 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective test for diagnosing Raynaud's phenomenon, based on thermal entrainment, non-invasive measurement of blood-flow responses.
Number of subjects: 0
Study 6401507 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 0
Study 31278808 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (LAMB)
Number of subjects: 0
Study 31278808 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate (MA)
Number of subjects: 0
Study 31278808 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMB plus Meglumine antimoniate (MA)
Number of subjects: 0
Study 31278808 — intervention group
Group type: COMPARATOR
Intervention: LAMB vs MA
Number of subjects: 0
Study 29046406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Extrusion Rice (CER)
Number of subjects: 41
Study 29046406 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Extrusion Rice 2 (HER2)
Number of subjects: 41
Study 29046406 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated Rice (COR)
Number of subjects: 41
Study 29046406 — intervention group
Group type: COMPARATOR
Intervention: Hot Extrusion Rice (HER)
Number of subjects: 41
Study 27602665 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (loading dose of 80 mg followed by 40 mg every 2 weeks)
Number of subjects: 217
Study 27602665 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 217
Study 27602665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 25000269 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile intervention for 14 days
Number of subjects: 94
Study 25000269 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile assessments (without intervention) for 14 days
Number of subjects: 94
Study 25000269 — intervention group
Group type: COMPARATOR
Intervention: Minimal assessments (without intervention or mobile assessments)
Number of subjects: 94
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Corneal nerve fiber length (CNFL)
Number of subjects: 89
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Fiber density
Number of subjects: 89
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Branch density
Number of subjects: 89
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Tortuosity
Number of subjects: 89
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Alternate threshold for sensitivity
Number of subjects: 89
Study 22323412 — intervention group
Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Alternate threshold for specificity
Number of subjects: 89
Study 19745215 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine
Number of subjects: 176
Study 19745215 — intervention group
Group type: COMPARATOR
Intervention: Nonadjuvanted vaccine
Number of subjects: 176
Study 17274828 — intervention group
Group type: EXPERIMENTAL
Intervention: CQR-300 (300 mg daily)
Number of subjects: 168
Study 17274828 — intervention group
Group type: EXPERIMENTAL
Intervention: CORE (1028 mg daily)
Number of subjects: 168
Study 17274828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 16227771 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy initiated in-hospital
Number of subjects: 0
Study 16227771 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 0
Study 11904654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (5 microg/kg per min) for 72 h
Number of subjects: 42
Study 11904654 — intervention group
Group type: COMPARATOR
Intervention: Saline for 72 h
Number of subjects: 42
Study 9461368 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with ALTE
Number of subjects: 26
Study 9461368 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study 7888977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment (16 hours per day for 18 weeks)
Number of subjects: 1200
Study 7888977 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch treatment
Number of subjects: 1200
Study 7888977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment with gradual reduction
Number of subjects: 1200
Study 7888977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment with dose increase after week 1
Number of subjects: 1200
Study 7888977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment
Number of subjects: 1200
Study 2198812 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% betaxolol ophthalmic solution
Number of subjects: 352
Study 2198812 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% betaxolol suspension
Number of subjects: 352
Study 857138 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/die Allopurinol
Number of subjects: 12
Study 857138 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/die Benzbromarone
Number of subjects: 12
Study 857138 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Allopurinol with 20 mg Benzbromarone
Number of subjects: 12
Study 857138 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 12
Study 31852312 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 183
Study 31852312 — intervention group
Group type: COMPARATOR
Intervention: Home wound care professional
Number of subjects: 183
Study 31852312 — intervention group
Group type: COMPARATOR
Intervention: Wound care clinic
Number of subjects: 183
Study 31852312 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine and home health care groups
Number of subjects: 183
Study 31852312 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 183
Study 30924163 — intervention group
Group type: EXPERIMENTAL
Intervention: EA-230 (90 mg/kg/hour for 2 hours)
Number of subjects: 80
Study 30924163 — intervention group
Group type: COMPARATOR
Intervention: EA-230 (1, 3, 10, or 30 mg/kg single dosage)
Number of subjects: 80
Study 30924163 — intervention group
Group type: COMPARATOR
Intervention: EA-230 (10, 20, or 30 mg/kg, thrice daily for 3 days)
Number of subjects: 80
Study 30924163 — intervention group
Group type: COMPARATOR
Intervention: EA-230 (15, 30, or 90 mg/kg/hour for 2 hours)
Number of subjects: 80
Study 29354954 — intervention group
Group type: EXPERIMENTAL
Intervention: No.1 treatment group (ginger-prepared paste)
Number of subjects: 160
Study 29354954 — intervention group
Group type: EXPERIMENTAL
Intervention: No.2 treatment group (honey-prepared paste)
Number of subjects: 160
Study 29354954 — intervention group
Group type: EXPERIMENTAL
Intervention: No.3 treatment group (honey-prepared paste, 6h application)
Number of subjects: 160
Study 29354954 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (pseudo-herbal paste)
Number of subjects: 160
Study 25158837 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture (knee, scalp, and auricular acupuncture)
Number of subjects: 60
Study 25158837 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular acupuncture
Number of subjects: 60
Study 22771110 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 20
Study 22771110 — intervention group
Group type: COMPARATOR
Intervention: Placebo Taping (PT)
Number of subjects: 20
Study 20544178 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of calcium and 400 IU of vitamin D3
Number of subjects: 40
Study 20544178 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study 18927162 — intervention group
Group type: EXPERIMENTAL
Intervention: General group-based exercise (GE) programme composed of resistance training and balance training exercises
Number of subjects: 154
Study 18927162 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility exercise and relaxation technique (FR) programme
Number of subjects: 154
Study 18927162 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control (NEC)
Number of subjects: 154
Study 17013513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell Saver (intraoperative red blood cell salvage)
Number of subjects: 41
Study 17013513 — intervention group
Group type: COMPARATOR
Intervention: No Cell Saver (control group)
Number of subjects: 41
Study 15380859 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine, 5-20 mg/day for 8 months
Number of subjects: 92
Study 11576934 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 50
Study 11576934 — intervention group
Group type: COMPARATOR
Intervention: Continuous Ambulatory Peritoneal Dialysis (CAPD)
Number of subjects: 50
Study 9462601 — intervention group
Group type: COMPARATOR
Intervention: Short-term fractal scaling exponent (alpha1)
Number of subjects: 38
Study 9462601 — intervention group
Group type: COMPARATOR
Intervention: Long-term fractal scaling exponent (alpha2)
Number of subjects: 38
Study 9462601 — intervention group
Group type: COMPARATOR
Intervention: Approximate entropy
Number of subjects: 38
Study 9462601 — intervention group
Group type: COMPARATOR
Intervention: Standard deviation of all RR intervals
Number of subjects: 38
Study 9462601 — intervention group
Group type: COMPARATOR
Intervention: High-frequency spectral component of HR variability
Number of subjects: 38
Study 8586772 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine Serum Albumin (BSA)
Number of subjects: 16
Study 8586772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovine Serum Albumin (OSA)
Number of subjects: 16
Study 8586772 — intervention group
Group type: COMPARATOR
Intervention: BSA and OSA
Number of subjects: 16
Study 2491707 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime-axetil (250 mg twice daily after meal)
Number of subjects: 150
Study 2491707 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil (1 g twice daily during meal)
Number of subjects: 150
Study 2491707 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime-axetil
Number of subjects: 150
Study 2491707 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil
Number of subjects: 150
Study 1062828 — intervention group
Group type: EXPERIMENTAL
Intervention: Training at 150 bpm heart rate
Number of subjects: 43
Study 1062828 — intervention group
Group type: EXPERIMENTAL
Intervention: Training 5 days/week
Number of subjects: 43
Study 1062828 — intervention group
Group type: EXPERIMENTAL
Intervention: Training 3 days/week
Number of subjects: 43
Study 1062828 — intervention group
Group type: COMPARATOR
Intervention: Training 1 day/week
Number of subjects: 43
Study 1062828 — intervention group
Group type: EXPERIMENTAL
Intervention: Training 5 days/week vs 3 days/week
Number of subjects: 43
Study 31934865 — intervention group
Group type: EXPERIMENTAL
Intervention: Online pain education program delivered through WeChat for 4 weeks
Number of subjects: 95
Study 31934865 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 95
Study 31745044 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonophoresis with aceclofenac gel
Number of subjects: 50
Study 31745044 — intervention group
Group type: COMPARATOR
Intervention: Plain ultrasound
Number of subjects: 50
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive frame
Number of subjects: 591
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral frame
Number of subjects: 591
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative frame
Number of subjects: 591
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Trolley problem
Number of subjects: 591
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Footbridge dilemma
Number of subjects: 591
Study 28558527 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of saved lives (5 or 15)
Number of subjects: 591
Study 25816865 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational Enablement Protocol (VEP)
Number of subjects: 66
Study 23636029 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology therapy (AEDs + reflexology therapy)
Number of subjects: 77
Study 23636029 — intervention group
Group type: COMPARATOR
Intervention: Antiepileptic drugs (Control)
Number of subjects: 77
Study 21305237 — intervention group
Group type: EXPERIMENTAL
Intervention: self-awareness plus compensatory prospective memory training
Number of subjects: 45
Study 21305237 — intervention group
Group type: COMPARATOR
Intervention: self-awareness training plus active control
Number of subjects: 45
Study 21305237 — intervention group
Group type: EXPERIMENTAL
Intervention: active control plus compensatory prospective memory training
Number of subjects: 45
Study 21305237 — intervention group
Group type: COMPARATOR
Intervention: active control only
Number of subjects: 45
Study 20029710 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE genotype information
Number of subjects: 271
Study 20029710 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater AD treatment optimism
Number of subjects: 271
Study 20029710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower perceived risk
Number of subjects: 271
Study 20029710 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived importance of genetics in the development of AD
Number of subjects: 271
Study 20029710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower perceived drawbacks of AD genetic testing
Number of subjects: 271
Study 16484699 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (100 mg/d orally, escalated to 400 mg/d)
Number of subjects: 60
Study 16484699 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone (300 mg orally daily)
Number of subjects: 60
Study 16484699 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 60
Study 16484699 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone
Number of subjects: 60
Study 12723460 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2%
Number of subjects: 12
Study 12723460 — intervention group
Group type: COMPARATOR
Intervention: Diprivan
Number of subjects: 12
Study 10651680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 100
Study 10651680 — intervention group
Group type: COMPARATOR
Intervention: No cricoid pressure (Control)
Number of subjects: 100
Study 8866631 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (1 mg)
Number of subjects: 13
Study 8866631 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil (60 mg)
Number of subjects: 13
Study 8866631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2023783 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating gait orthosis (RGO)
Number of subjects: 22
Study 2023783 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip guidance orthosis (HGO)
Number of subjects: 22
Study 2023783 — intervention group
Group type: EXPERIMENTAL
Intervention: Neither orthosis
Number of subjects: 22
Study 2023783 — intervention group
Group type: COMPARATOR
Intervention: Cost comparison
Number of subjects: 22